Lilly's Obesity Drug Sales Rise 60% in India Amid Rising Demand
Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full month of being on offer in the South Asian country, which has the world's third-highest number of obese people.
The US drugmaker sold 126 million rupees ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies. Sales of its 5 mg version more than doubled to about 75 million rupees, while revenue from the 2.5 mg shot was 51 million rupees.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
2 hours ago
- New York Post
Weight loss drugs like Ozempic could mess with your birth control — and get you pregnant
A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the medications. The warning comes as women flood social media with stories of their so-called 'Ozempic babies' — including surprise pregnancies while on the pill. Trying to shed pounds, not grow a baby bump? Here's what you need to know about GLP-1s, pregnancy and the best contraception options to stay protected. 4 Studies show that at least one in eight US adults have tried GLP-1s. íÅí°íâ¬í¸í½í° íâíµí¼íµíËí°í¾ – What's in your GLP-1? Several GLP-1 drugs dominate the market, including Ozempic and Wegovy. Both contain semaglutide, an active ingredient that mimics a natural hormone in the body that boosts insulin production, slows digestion and curbs appetite. Then there's Saxenda and Victoza, powered by liraglutide, which functions in a similar way. Newer drugs like Mounjaro and Zepbound rely on tirzepatide, a key ingredient that targets a second hormone involved in appetite and blood sugar control. A surprise side effect While gastrointestinal symptoms like nausea, vomiting and diarrhea are common with GLP-1s, the surprise side effect making waves is unexpected pregnancy. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has received 28 reports related to pregnancy in patients on tirzepatide, and nine each for semaglutide and liraglutide. 4 Women on tirzepatide-based GLP-1s should use barrier contraception. nenetus – In an alert this week, the agency warned that tirzepatide may reduce the effectiveness of oral contraceptives, especially in women with higher body weight. As a result, it recommended using barrier methods like condoms while on drugs like Mounjaro. So far, there's no evidence that GLP-1s affect non-oral birth control like IUDs, implants, patches, or rings, according to the UK's Faculty of Reproductive Healthcare. And yes, the advice applies even to women previously told they were infertile. GLP-1s have been shown to boost fertility by aiding weight loss, reducing inflammation and improving insulin sensitivity — leading some to conceive just months after starting treatment. 4 GLP-1 agonists can increase your fertility, but they can also interfere with pregnancy. Louis-Photo – Can you take GLP-1s while pregnant? Experts say no — at least not yet. There's not enough data to confirm whether GLP-1s are safe during pregnancy. While a some human studies suggests there is no harm in first-trimester use, testing in animals has shown the drugs could increase the risk of miscarriage and birth defects. 4 Scientists are still working to understand whether GLP-1s can negatively impact a developing fetus. Evrymmnt – Another reason to skip GLP-1s while pregnant: they suppress your appetite and can trigger gastrointestinal issues, which may lead to nutrient deficiencies that impact fetal development. The drugs should also be avoided during breastfeeding, since there's not enough research to confirm safety for infants. Trying to conceive? Here's the timeline If you're planning to get pregnant, the MHRA recommended stopping GLP-1s before you start trying to conceive and giving your body time to clear the drugs. For semaglutide users, that means quitting at least two months ahead. If you're on tirzepatide, stop one month before trying. Liraglutide clears the system faster, so you can stop right before you start trying to conceive.
Yahoo
2 hours ago
- Yahoo
India, U.S. trade talks extend into next week, Reuters reports
Trade talks between Indian and U.S. officials have been extended into next week as both sides seek consensus on tariff cuts in the farming and auto sectors, Manoj Kumar of Reuters reports, citing Indian government sources. Negotiators, who had initially aimed to wrap up talks by Friday, will now continue discussions on Monday and Tuesday to resolve outstanding differences, a second Indian official told Reuters. Both sides are aiming to finalize an interim deal before a July 9 deadline, the sources added. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on SPY: Disclaimer & DisclosureReport an Issue Trump pushes for 'full point' rate cut on social media May U.S. nonfarm payrolls rise 139,000, unemployment rate remains 4.2% SPDR S&P 500 ETF Trust: Pivot points Stock Market News Today, 6/6/25 – Futures Up as Market Eyes Jobs Data Over Musk-Trump Feud Trump says OBBB 'one of the greatest bills ever presented to Congress'
Yahoo
2 hours ago
- Yahoo
Millions more to get test results via NHS app, government says
The NHS app will become the default method of communication for millions more patients in England and save the health service £200m over the next three years, the government has said. More test results, screening invitations and appointment reminders will be sent directly to smartphones as part of a £50m investment in the app, in a move away from traditional communication methods such as letters. It is estimated that at least 50 million letters are sent to patients each year. The Department of Health and Social Care said that people who cannot access app messaging - including elderly patients - will receive text messages and then a letter as a last resort, and NHS phone lines would be freed up. The department says 270 million messages will be sent through the NHS app this financial year - an increase of 70 million on the previous year. Push notifications will provide appointment reminders to patients to try to reduce the risk of no attendance - with around eight million missed appointments in elective care missed in 2023/24. Work is also under way to enable users of the app to add appointments to their phone calendars and request help from their local GP surgeries. Figures show that more than 11 million people in the UK log into the NHS app every month, while almost 20 million are opted in to receive healthcare messages from the app. It is hoped the changes will give patients better access to manage their healthcare journey and make informed decisions about their care. NHS app services, which were launched in December 2018, are now used in 87% of hospitals across England. Health Secretary Wes Streeting said further investment in the app would bring the NHS into the digital age so that being a patient was as "convenient as online banking or ordering a takeaway". He added that moving away from paper communication could free up funding for front line services. Rachel Power, chief executive of the Patient's Association, said the upgrade was a "significant step in modernising how patients receive information". The British Medical Association (BMA) has previously warned that a reliance on apps to the NHS to communicate with patients risked alienating patients who don't have access to digital technology. It followed the government's announcement in January that it planned to allow more patients in England to book treatments and appointments through the app. Last month, NHS England announced millions of patients would be able to get "Amazon-style" tracking updates on their prescriptions through the app, to check if their medicines are ready to collect or have been despatched for delivery. New app trial cuts skin cancer referrals by 50% NHS App upgrade to give patients more choice over treatment Patients to get full access to record on NHS App
